Notice of Meeting of the Working Group To Advise the ACD on Guidelines and Oversight Process for Research Involving Human Pluripotent Stem Cells

[Federal Register Volume 64, Number 63 (Friday, April 2, 1999)]
[Notices]
[Page 15980]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-8096]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Notice of Meeting of the Working Group To Advise the ACD on 
Guidelines and Oversight Process for Research Involving Human 
Pluripotent Stem Cells

    Notice is hereby given that the Working Group of the Advisory 
Committee to the Director (ACD), NIH to advise the ACD on guidelines 
and oversight for research involving human pluripotent stem cells, will 
meet in public session at the Bethesda Marriott, 5151 Pooks Hill Road, 
Bethesda, Maryland 20814, on April 8, 1999. The meeting will begin at 
approximately 9:00 a.m. and end at approximately 5:30 p.m.
    The goal of the Working Group is to provide advice to the ACD about 
the scientific, ethical, legal, and social issues relevant to 
guidelines for the conduct of research utilizing human pluripotent stem 
cells (cells that can form most of the cells and tissues of the body) 
and to consider oversight options for this research.
    A limited amount of meeting time will be allotted for public 
testimony. Individuals who wish to give five minute public testimony 
may sign up at the meeting site the morning of the meeting on a first 
come, first served basis. Written testimony may be submitted to: the 
Office of Science Policy, Bldg. 1, Room 218, NIH, 9000 Rockville Pike, 
Bethesda 20892.
    Attendance may be limited to seat availability.
Ruth L. Kirschstein,
Deputy Director, NIH.
[FR Doc. 99-8096 Filed 4-1-99; 8:45 am]
BILLING CODE 4140-01-P